Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Bobthebuilddron Jan 08, 2017 1:25pm
78 Views
Post# 25680609

RE:Germany

RE:GermanyAlthough I like the Germany expansion. The benefit of it will not be seen for years and therefor I don't think really affects the current valuation. Germany is still in its infancy. And there are barely any strains available to there residents. Something like 7 nationwide. It is covered by some insurances, but there is only like 900 clients nationwide atm in Germany. And the average sale cost is 15$ which is way too high so they just buy it from the black market. Germany to me is a 3+ year play with big potential. But way to far in the future to be counted on.
RainbowRunner wrote: Article from Dec. 22 ... 

Germany

Maybe taking the executive to Berlin qualifies as an unusual expense? ...

"With the growing awareness of marijuana’s potential therapeutic benefits for a variety of ailments, the German people are aggressively pursuing policies which allow for increased production and use of the cannabis plant. If you are interested in learning more about the upcoming German and European markets and want to know more about their changing laws regarding cannabis, join the cadre of experts who will be attending the International Cannabis Business Conference in Berlin, Germany on April 10-12."


Bullboard Posts